0775:HKG
CK Life Sciences Intl (Holdings) Inc
HK$0.51
0.00%
(0.00) 1D
10월 16일, 오후 4시 8분 14초 GMT+8 · HKD
search
모든 종목 코드
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_auto0775의 주요 통계 생성 중...
시가
HK$0.51
고가
HK$0.52
저가
HK$0.51
시가총액
48.56억
평균 거래량
166.34만
거래량
95.60만
52주 최고가
HK$1.02
52주 최저가
HK$0.51
EPS
-HK$0.01
유통 주식수
96.11억
직원 수
2천
시가
HK$0.51
고가
HK$0.52
저가
HK$0.51
시가총액
48.56억
평균 거래량
166.34만
거래량
95.60만
52주 최고가
HK$1.02
52주 최저가
HK$0.51
EPS
-HK$0.01
유통 주식수
96.11억
직원 수
2천
뉴스 기사
웹 소스 및 뉴스 파트너 제공
프로필
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
CK Life Sciences Intl (Holdings) Inc에 관한 정보